KI-Beratung für Unternehmensethik

Heim

KI-Prompt-Liste

Philosophie/Religion

Ethische Entscheidungsunterstützung

${:__('collect %s',Ethische Entscheidungsunterstützung)}$

Philosophie/Religion

Bietet eine ausgewogene Analyse basierend auf Utilitarismus und Deontologie für moralische Dilemmata im Geschäftsverkehr und unterstützt Manager bei der Entscheidungsfindung im Einklang mit Werten.

Prompt-Inhalt

Kopieren

Act as a corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Recalling it would cause massive financial losses and affect shareholder interests, while not recalling it might harm patient health. Please analyze the moral weight of both recall and non-recall paths by combining utilitarian consequence assessment with deontological respect for the dignity of life, and propose a balanced solution that considers both social responsibility and corporate sustainability, focusing on how to rebuild public trust through transparent communication.

Kopieren

Treten Sie als Unternehmensethikberater auf, um Entscheidungsempfehlungen für das folgende spezifische Geschäftsszenario zu geben: Ein Pharmaunternehmen stellt fest, dass sein meistverkauftes Medikament bei langfristiger Anwendung leichte, aber unzureichend offengelegte Nebenwirkungen hat. Eine Rückrufaktion würde zu massiven finanziellen Verlusten führen und die Interessen der Aktionäre beeinträchtigen, während ein Unterlassen die Gesundheit der Patienten schädigen könnte. Bitte analysieren Sie das moralische Gewicht beider Wege, Rückruf und Nicht-Rückruf, indem Sie die utilitaristische Folgenabschätzung mit dem deontologischen Respekt vor der Menschenwürde kombinieren, und schlagen Sie eine ausgewogene Lösung vor, die sowohl soziale Verantwortung als auch Unternehmensnachhaltigkeit berücksichtigt, mit Schwerpunkt darauf, wie das öffentliche Vertrauen durch transparente Kommunikation wiederhergestellt werden kann.

Kopieren

Teilen Klicken Sie, um den Link zu kopieren

Kommentare (1)

0/300

Einreichen

RaymondGreen

30. August 2026 14:26:33 MESZ

このプロンプト、製薬会社の倫ジックなジレンマを扱ってて深いな。功利主義と義務論の両面から分析させるのが秀逸。実際に使えば、単なる利益追求じゃなく、信頼回復の具体的なコミュニケーション戦略まで提案してくれそう。企業倫理の勉強や社内研修に使いやすそう。構造的でわかりやすいから、迷わず試してみたい！✨

Empfehlung

Ethische Entscheidungsunterstützung

Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its existing basic drug has minor but non-fatal long-term side effects. The cost of recall is extremely high and could lead to bankruptcy, affecting millions of patients' continuous medication, while not recalling it might harm some patients' health. Please evaluate the moral weight of both recall and non-recall options from the perspectives of utilitarianism, deontology, and virtue ethics, identify key stakeholders and their potential harms, and provide a balanced decision recommendation that balances corporate survival and patient well-being, focusing on the ethical logic behind the decision rather than mere legal compliance.

Ethische Entscheidungsunterstützung

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, yet discontinuing the medication poses higher health risks. Please evaluate the ethical weights of three options—continuing sales, recalling, or modifying labels—by integrating both utilitarian (greatest good for the greatest number) and deontological (respect for patient autonomy and non-maleficence) frameworks. Avoid simplistic right-or-wrong judgments; instead, deeply explore the conflict of rights and obligations among stakeholders (patients, shareholders, regulators). Finally, output a decision recommendation report that balances commercial responsibility with moral duty, emphasizing transparent communication and prioritizing patient well-being.

Ethische Entscheidungsunterstützung

Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its existing basic drug has minor but non-fatal side effects, and the recall cost is extremely high, potentially causing some patients to lose access to medication. Please evaluate the moral weight of both recalling and not recalling the drug by combining the impact on the greatest number of people under utilitarianism with patient informed consent and safety responsibilities under deontology, and provide a balanced recommendation that considers both business sustainability and patient well-being, focusing on the ethical logic behind the decision rather than mere legal compliance.

Ethische Entscheidungsunterstützung

Act as a corporate ethics consultant to analyze potential privacy invasion and algorithmic bias issues arising from AI system usage of customer data. Apply utilitarian and deontological ethical frameworks to evaluate the long-term impact of different handling options on stakeholders, identify potential moral risk points, and provide a set of decision-making recommendations that balance commercial efficiency with ethical bottom lines, ensuring the final plan complies with laws and regulations while reflecting humanistic care.

Ethische Entscheidungsunterstützung

Please analyze the ethical conflict between privacy protection and public safety faced by a multinational tech company developing an AI facial recognition system, evaluate the rights of different stakeholders from the perspectives of utilitarianism and deontology, and provide decision-making advice that balances technological innovation with social responsibility.

Ethische Entscheidungsunterstützung

Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers minor but non-fatal side effects during clinical trials that may affect long-term patient quality of life, yet the drug can save thousands of lives with no alternatives. Combine the utilitarian principle of maximizing happiness with the deontological principle of respecting life to analyze whether clinical trials should proceed, and provide balanced advice considering legal compliance, public trust, and patient rights, avoiding absolute moral judgments in favor of a stakeholder-based decision path.